Monetary Management Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-650
Closed -$58K – 312
2021
Q1
$58K Hold
650
– – 0.02% 233
2020
Q4
$61K Hold
650
– – 0.02% 221
2020
Q3
$41K Hold
650
– – 0.01% 224
2020
Q2
$34K Buy
650
+200
+44% +$8.58K 0.01% 225
2020
Q1
$14K Hold
450
– – 0.01% 246
2019
Q4
$15K Hold
450
– – 0.01% 280
2019
Q3
$13K Hold
450
– – ﹤0.01% 284
2019
Q2
$16K Buy
+450
New +$14.4K 0.01% 277

Other funds holding ARKG

Monetary Management Group's ARKG Position: Q2 2021 in Review

Monetary Management Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 650 shares — an estimated $58K sold.

Monetary Management Group first reported a position in ARKG in Q2 2019 and held it in 8 quarters. The position peaked at $61K in Q4 2020. 514 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • Monetary Management Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
  • Monetary Management Group sold 650 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $58K.
  • Monetary Management Group first reported a position in ARK Genomic Revolution ETF in Q2 2019 and held it in 8 quarters.
  • Monetary Management Group's ARK Genomic Revolution ETF position peaked at $61K in Q4 2020.
  • 514 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on Monetary Management Group's 13F filing for Q2 2021, filed 12 Aug 2021.